Physician profile
Mark O Catron
NPI 1811933989
$241.99
in general payments reported to CMS, 2019-2025
9 companies · $30.21 in 2025
The $30.21 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $103 · 2022: $38.34 · 2023: $19.56 · 2024: $50.73 · 2025: $30.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $100.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $69.78 | 2021-2022 | |
| Glaxosmithkline, LLC. | $36.30 | 2021-2024 | Arexvy, Trelegy Ellipta |
| Exact Sciences Corporation | $31.59 | 2024-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $27.46 | 2021 | |
| Lilly USA, LLC | $19.56 | 2023 | Jardiance |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.00 | 2024 | Caplyta |
| Astrazeneca Pharmaceuticals LP | $15.36 | 2025 | Breztri |
| Abbvie INC. | $13.92 | 2021 | |
| Genentech USA, INC. | $10.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Catron listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.